Chemoinformaics analysis of Ethyl acetate
| Molecular Weight | 88.106 | nRot | 1 |
| Heavy Atom Molecular Weight | 80.042 | nRig | 3 |
| Exact Molecular Weight | 88.0524 | nRing | 0 |
| Solubility: LogS | -5.38 | nHRing | 0 |
| Solubility: LogP | 6.242 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 14 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 13.6183 |
| nHD | 0 | BPOL | 10.6297 |
| QED | 0.334 |
| Synth | 2.397 |
| Natural Product Likeliness | 1.745 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.685 |
| Pgp-sub | 0.004 |
| HIA | 0.004 |
| CACO-2 | -4.479 |
| MDCK | 0.0000218 |
| BBB | 0.257 |
| PPB | 0.962237 |
| VDSS | 4.103 |
| FU | 0.0340864 |
| CYP1A2-inh | 0.978 |
| CYP1A2-sub | 0.155 |
| CYP2c19-inh | 0.676 |
| CYP2c19-sub | 0.238 |
| CYP2c9-inh | 0.712 |
| CYP2c9-sub | 0.854 |
| CYP2d6-inh | 0.135 |
| CYP2d6-sub | 0.073 |
| CYP3a4-inh | 0.403 |
| CYP3a4-sub | 0.184 |
| CL | 14.635 |
| T12 | 0.313 |
| hERG | 0.021 |
| Ames | 0.004 |
| ROA | 0.024 |
| SkinSen | 0.945 |
| Carcinogencity | 0.213 |
| EI | 0.936 |
| Respiratory | 0.208 |
| NR-Aromatase | 0.032 |
| Antiviral | No |
| Prediction | 0.984927 |